| Krebserkrankungen bei Kindern: Erfolg durch einheitliche Therapiekonzepte seit 25 Jahren U Creutzig, G Henze, S Bielack, R Herold, P Kaatsch, JH Klussmann, ... Dtsch Arztebl 100 (13), A842 / B-712 / C-665, 2003 | 148* | 2003 |
| Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia A Karachunskiy, R Herold, A Von Stackelberg, N Miakova, A Timakow, ... Leukemia 22 (6), 1144-1153, 2008 | 97 | 2008 |
| Role of modeling and simulation in pediatric investigation plans E Manolis, TE Osman, R Herold, F Koenig, P Tomasi, S Vamvakas, ... Pediatric Anesthesia 21 (3), 214-221, 2011 | 96 | 2011 |
| Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood A Borgmann, C Zinn, R Hartmann, R Herold, P Kaatsch, G Escherich, ... European journal of cancer 44 (2), 257-268, 2008 | 96 | 2008 |
| The pulmonary surfactant system: biological functions, components, physicochemical properties and alterations during lung disease U Pison, R Herold, S Schürch Colloids and Surfaces A: Physicochemical and Engineering Aspects 114, 165-184, 1996 | 70 | 1996 |
| Implementation of mechanism of action biology-driven early drug development for children with cancer ADJ Pearson, R Herold, R Rousseau, C Copland, B Bradley-Garelik, ... European Journal of Cancer 62, 124-131, 2016 | 68 | 2016 |
| Induction of apoptosis by enediyne antibiotic calicheamicin ϑ II proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner A Prokop, W Wrasidlo, H Lode, R Herold, F Lang, G Henze, B Dörken, ... Oncogene 22 (57), 9107-9120, 2003 | 67 | 2003 |
| Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE N Gaspar, LV Marshall, D Binner, R Herold, R Rousseau, P Blanc, ... Annals of Oncology 29 (3), 766-771, 2018 | 66 | 2018 |
| A European network of paediatric research at the European Medicines Agency (Enpr-EMA) N Ruperto, I Eichler, R Herold, G Vassal, C Giaquinto, L Hjorth, ... Archives of disease in childhood 97 (3), 185-188, 2012 | 51 | 2012 |
| Accelerating drug development for neuroblastoma-new drug development strategy: an innovative therapies for children with cancer, European network for cancer research in … L Moreno, H Caron, B Geoerger, A Eggert, G Schleiermacher, P Brock, ... Expert opinion on drug discovery 12 (8), 801-811, 2017 | 50 | 2017 |
| Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster group (ALL-REZ BFM) experience: Early treatment intensity makes the difference R Herold, A von Stackelberg, R Hartmann, B Eisenreich, G Henze Journal of clinical oncology 22 (3), 569-570, 2004 | 49 | 2004 |
| Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial M Krischke, G Hempel, S Völler, N André, M D’Incalci, G Bisogno, ... Cancer chemotherapy and pharmacology 78, 1175-1184, 2016 | 38 | 2016 |
| The impact of COVID‐19 on the initiation of clinical trials in Europe and the United States F Lasch, EE Psarelli, R Herold, A Mattsson, L Guizzaro, F Pétavy, A Schiel Clinical Pharmacology & Therapeutics 111 (5), 1093-1102, 2022 | 36 | 2022 |
| 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children R Herold, M Becker BMC gastroenterology 2, 1-6, 2002 | 33 | 2002 |
| The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation F Pignatti, I Gravanis, R Herold, S Vamvakas, B Jonsson, M Marty Clinical Cancer Research 17 (16), 5220-5225, 2011 | 31 | 2011 |
| Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus U Felderhoff-Mueser, R Herold, F Hochhaus, P Koehne, E Ring-Mrozik, ... Archives of disease in childhood 84 (4), 369-372, 2001 | 30 | 2001 |
| Milling machine and milling process M Zimmermann, J Boehm, R Herold US Patent 6,666,630, 2003 | 29 | 2003 |
| Pharmacometrics for regulatory decision making E Manolis, R Herold Clinical pharmacokinetics 50 (10), 625-626, 2011 | 24 | 2011 |
| Cerebrospinal fluid soluble L-selectin (sCD62L) in meningoencephalitis. C Bührer, R Herold, D Stibenz, G Henze, M Obladen Archives of disease in childhood 74 (4), 288-292, 1996 | 24 | 1996 |
| EMA recommendation for the pediatric indications of plerixafor (Mozobil) to enhance mobilization of hematopoietic stem cells for collection and subsequent autologous … D Karres, S Ali, PB van Hennik, S Straus, F Josephson, G Thole, ... The Oncologist 25 (6), e976-e981, 2020 | 23 | 2020 |
